Rapid Cardiovascular Disease Test

The LumiraDx D-Dimer Test is a microfluidic immunoassay that is both fast and user-friendly, and it is specifically engineered to rapidly quantify D-Dimer levels in either whole blood or plasma. It is the sole direct fingerstick D-Dimer assay currently available, enabling healthcare professionals to confidently rule out pulmonary embolism (PE) and deep vein thrombosis (DVT) in symptomatic patients in just six minutes**.input:
output:The LumiraDx D-Dimer Test is an in vitro diagnostic test that quantifies D-Dimer in human capillary and venous whole blood and plasma samples (Sodium Citrate). The LumiraDx D-Dimer Test Strips are designed for use in conjunction with the LumiraDx Instrument. It is an automated in vitro diagnostic test designed for near-patient testing to assist in the assessment and diagnosis of patients with suspected venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT).input:
output:The test can be employed in conjunction with a clinical pre-test probability assessment model to rule out pulmonary embolism (PE) and deep vein thrombosis (DVT) in patients who are suspected of having PE or DVT. The LumiraDx D-Dimer test is intended for professional use only. For patients who are at least 18 years old.Benefits of testinginput:
output:The LumiraDx D-Dimer Test enhances efficiency in primary and secondary care settings by providing a rapid evaluation of patients who exhibit symptoms of pulmonary embolism (PE) and deep vein thrombosis (DVT).input:
output:Clinical Cut-off: 0.500 mg/L FEU, 500 µg/L FEUinput:
output:Direct fingerstick samplingStorage of Test Strips at room temperatureinput:
output:Precision: ≤11.1% CVinput:
output:Test the workflow.input:
output:In an effort to guarantee that the instrument and test strips are functioning properly during each test run, they are integrated with numerous quality control checks.